The Latest Cardiac and Vascular News
VitalStream™, Featuring Patented Pulse Decomposition Analysis™ technology becomes the World’s First Wireless Wearable Monitor for Continuous Blood Pressure and Advanced Hemodynamics – All with a single, easy-to-apply Finger Sensor Caretaker Medical, a digital health leader in continuous “beat by beat” wireless patient monitoring technologies, today announced that it has received […]
SAN FRANCISCO–(BUSINESS WIRE)–Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study achieved statistically significant results of 98.7% in accurately identifying the regional arrhythmia source location for premature ventricular complex (PVC) and ventricular tachycardia (VT), 96.9% in accurately […]
CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a commitment letter from Deerfield Management Company (“Deerfield”), to refinance its existing debt with a new […]
– Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress – MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) — Volta Medical, a pioneering medtech startup advancing novel artificial intelligence (AI) algorithms to treat cardiac arrhythmias, today announced it […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). The first implant was done by Duc Thinh Pham, MD, and Jane Wilcox, MD, at […]
tenacio announces the publication of “Universal Clinician Device for improving risk prediction and management of patients with atrial fibrillation. An assumed benefit analysis” in the European Heart Journal Digital Health The in-silico study demonstrated expected outcome benefits of 23% reduction in mortality, 24% reduction in strokes and 14% in bleeding […]
LAKE OSWEGO, Ore., April 26, 2022 /PRNewswire/ — BIOTRONIK, Inc. announced today it has received U.S. Food and Drug Administration (FDA) approval of Renamic Neo, the company’s state-of-the-art programmer for implanted cardiac rhythm management devices such as ICDs, pacemakers, and implantable cardiac monitors. In addition to its programming functions, Renamic Neo now […]
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, today announced the completion of patient […]
CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce a worldwide milestone achievement as […]
Sale to an undisclosed medical device company will accelerate product development of innovative epicardial ablation technology BOSTON, April 25, 2022 /PRNewswire/ — NIDO Surgical announced today the acquisition of its innovative epicardial ablation technology, SEPIA (Solution for Epicardial Ablation), by an undisclosed medical device company involved in the electrophysiology space. As part of the transaction, […]
